Metastasis leads to a poor prognosis of patients with esophageal squamous cell carcinoma
(ESCC). 1-3 but the study on cancer metastasis has been hampered by a lack of reliable cell …

Background Novel therapies tailored to the molecular composition of esophageal squamous
cell carcinoma (ESCC) are needed to improve patient survival. We investigated the …

Statement of Retraction Jie Yan, Litong Shi, Shan Lin & Yi Li (2021) MicroRNA-624-
mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell …

Hepatocellular carcinoma (HCC) is an aggressive and fatal disease caused by a subset of
cancer stem cells (CSCs). It is estimated that there are approximately 100 000 long …

OBJECTIVE: Chemoresistance is the leading cause of recurrence in non-small cell lung
cancer (NSCLC). The long non-coding RNA (lncRNA) cancer susceptibility candidate 2 …

Abstract Long noncoding RNA (lncRNA) OIP5‐AS1 was shown to facilitate drug resistance
and metastasis in several tumors. As cancer stem cells (CSCs) have been elucidated as the …

Background Drug resistance restrains the effect of drug therapy in non-small cell lung
cancer (NSCLC). However, the mechanism of the acquisition of drug resistance remains …

Tumor hypoxia has been recognized as a characteristic of the tumor microenvironment and
promotes metastasis in a variety of types of cancer. However, in lung cancer, the role of …

Tumor-associated macrophages (TAM) are among the most abundant immune cells in the
tumor microenvironment and are important mediators of tumor development and …

Esophageal cancer (EC) is an aggressive form of cancer, including squamous cell
carcinoma (ESCC) and adenocarcinoma (EAC) as two predominant histological subtypes …